Search results for "Pneumonectomy"

showing 10 items of 50 documents

Free-Floating Mesothelial Cells in Pleural Fluid After Lung Surgery

2018

Objectives: The mesothelium, the surface layer of the heart, lung, bowel, liver and tunica vaginalis, is a complex tissue implicated in organ-specific diseases and regenerative biology; however, the mechanism of mesothelial repair after surgical injury is unknown. Previous observations indicated seeding of denuded mesothelium by free-floating mesothelial cells may contribute to mesothelial healing. In this study, we investigated the prevalence of mesothelial cells in pleural fluid during the 7 days following pulmonary surgery. Study design: Flow cytometry was employed to study pleural fluid of 45 patients after lung resection or transplantation. We used histologically validated mesothelial …

0301 basic medicinePathologymedicine.medical_specialtymedicine.medical_treatmentFlow cytometry03 medical and health sciencesPneumonectomy0302 clinical medicinepleural fluidlung healingmedicinepneumonectomyOriginal Researchmesothelial cellslcsh:R5-920Lungmedicine.diagnostic_testTunica vaginalisGeneral Medicine3. Good healthStainingMesotheliumTransplantation030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesislung regenerationMedicinelcsh:Medicine (General)Mesothelial CellFrontiers in Medicine
researchProduct

Single-Cell Transcriptional Profiling of Cells Derived From Regenerating Alveolar Ducts

2020

Lung regeneration occurs in a variety of adult mammals after surgical removal of one lung (pneumonectomy). Previous studies of murine post-pneumonectomy lung growth have identified regenerative “hotspots” in subpleural alveolar ducts; however, the cell-types participating in this process remain unclear. To identify the single cells participating in post-pneumonectomy lung growth, we used laser microdissection, enzymatic digestion and microfluidic isolation. Single-cell transcriptional analysis of the murine alveolar duct cells was performed using the C1 integrated fluidic circuit (Fluidigm) and a custom PCR panel designed for lung growth and repair genes. The multi-dimensional data set was …

0301 basic medicinewarburg effectAngiogenesisglucose metabolismmedicine.medical_treatmentPopulationCellBiology03 medical and health sciencesPneumonectomy0302 clinical medicineAlveolar ductSingle-cell analysismedicinemetabolic reprogrammingeducationaerobic glycolysisOriginal ResearchLaser capture microdissectionlcsh:R5-920education.field_of_studyLungGeneral MedicineCell biology030104 developmental biologymedicine.anatomical_structure030228 respiratory systemMedicinecholangiocarcinomalcsh:Medicine (General)Frontiers in Medicine
researchProduct

ROUTINARY USE OF FIBRIN SEALANTS TO PREVENT PROLONGED AIR LEAK IN THORACIC SURGERT: OUR EXPERIENCE

2019

Introduction: prolonged air leak (PAL) is one of the most common postoperative complications after lung surgery. It is associatred with increased significant morbidity, lower quality of life, longer hospital stay and higher hospital costs. Since its great clinical and economic burden, it is important to establish the feasibility and the effectiveness of the routinary preventive use of a fibrin sealant in order to reduce the incidence of prolonged air leaks. Patients and methods: this is a randomized study on 189 adult patients - 118 men (62,4%) and 71 women (37,6%) aged from 39 to 87 y.o. (mean age 68,3 y.o.) - who underwent lung surgery (lobectomy or bilobectomy) with intraoperatory detect…

AdultAged 80 and overMaleprolonged air leak pneumothorax alveolo-pleural fistula fibrin glue thoracic surgery lungAirSuture TechniquesAnastomotic LeakFibrin Tissue AdhesiveLength of StayMiddle AgedSettore MED/18 - Chirurgia GeneraleChest TubesQuality of LifeHumansFemaleTissue AdhesivesPneumonectomyAged
researchProduct

Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Smal…

2015

Purpose Concurrent chemoradiotherapy with or without surgery are options for stage IIIA(N2) non–small-cell lung cancer. Our previous phase II study had shown the efficacy of induction chemotherapy followed by chemoradiotherapy and surgery in patients with IIIA(N2) disease and with selected IIIB disease. Here, we compared surgery with definitive chemoradiotherapy in resectable stage III disease after induction. Patients and Methods Patients with pathologically proven IIIA(N2) and selected patients with IIIB disease that had medical/functional operability received induction chemotherapy, which consisted of three cycles of cisplatin 50 mg/m2 on days 1 and 8 and paclitaxel 175 mg/m2 on day 1 ev…

AdultMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsPaclitaxelmedicine.medical_treatmentMedizinPhases of clinical researchVinblastineVinorelbineDrug Administration SchedulePneumonectomyCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansPneumonectomyLung cancerAgedNeoplasm Stagingbusiness.industryDose fractionationInduction chemotherapyVinorelbineChemoradiotherapyInduction ChemotherapyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryRadiation therapyTreatment OutcomeOncologyFemaleDose Fractionation RadiationCisplatinbusinessChemoradiotherapymedicine.drugJournal of Clinical Oncology
researchProduct

The Influence of the Primary Tumor on the Long-term Results of Pulmonary Metastasectomy for Metastatic Renal Cell Carcinoma

2011

OBJECTIVE To investigate one of the primary tumor (PT) on pulmonary metastasectomy (PM) for metastatic renal cell carcinoma (RCC) and to define prognostic factors. METHODS Retrospective review of patients with pulmonary metastases from RCC from January 1999 through December 2008 was performed. All patients underwent PM with curative intend. TNM-classification, tumor stage and PT grade, disease-free-interval (DFI) from nephrectomy to the diagnosis of metastasis, systemic chemotherapy before surgical intervention, surgical procedures, morbidity, mortality, and survival were investigated. RESULTS One-hundred seven consecutive patients (age 61.5 ± 9.6 years) underwent PM. Morbidity and mortalit…

AdultMalePulmonary and Respiratory MedicineOncologymedicine.medical_specialtyLung NeoplasmsTime Factorsmedicine.medical_treatmentUrologyKaplan-Meier EstimateNephrectomyRisk AssessmentRisk FactorsRenal cell carcinomaInternal medicinemedicineAdjuvant therapyHumansPneumonectomyCarcinoma Renal CellAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overUnivariate analysisProportional hazards modelbusiness.industryMortality rateMetastasectomyMiddle Agedmedicine.diseasePrimary tumorKidney NeoplasmsNeoadjuvant TherapyNephrectomyTreatment OutcomeChemotherapy AdjuvantLymphatic MetastasisMultivariate AnalysisFemaleSurgeryNeoplasm GradingMetastasectomyCardiology and Cardiovascular MedicinebusinessThe Thoracic and Cardiovascular Surgeon
researchProduct

Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer

2008

Limited information exists on the incidence of symptomatic venous thromboembolism (vTE) in patients undergoing chest surgery for lung cancer. Several factors increase the thromboembolic risk in patients undergoing surgery for lung cancer: the intrinsic procoagulant effect of cancer,extensive surgical intervention, dependent limb position in the operating room, and vessel injury consequent to the operation. Furthermore,these patients might be especially vulnerable to pulmonary embolism (PE) because of the loss of lung tissue and the presence of chronic obstructive pulmonary disease and cardiovascular diseases caused by smoking.t Older studies found a very high incidence of thromboembolic eve…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentSeverity of Illness Indexvenous thromboembolism thoracotomySettore MED/15 - Malattie Del SangueCohort StudiesAge DistributionPostoperative ComplicationsRisk FactorsmedicineHumansMulticenter Studies as TopicThoracotomySex DistributionLung cancerPneumonectomyAgedNeoplasm StagingRetrospective StudiesAged 80 and overOntariobusiness.industryVascular diseaseIncidence (epidemiology)IncidenceRespiratory diseaseCancerAnticoagulantsRetrospective cohort studyVenous ThromboembolismMiddle Agedmedicine.diseasePrognosisSurvival AnalysisSurgeryVenous thrombosisItalyThoracotomyFemaleSurgerybusinessPulmonary EmbolismCardiology and Cardiovascular MedicineThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Bilobectomy for massive hemoptysis after bilateral lung transplantation

2001

AbstractJ Thorac Cardiovasc Surg 2001;121:1194-5

AdultMaleReoperationPulmonary and Respiratory Medicinemedicine.medical_specialtyHemoptysisCystic Fibrosismedicine.medical_treatmentRisk AssessmentSeverity of Illness IndexBilobectomyPneumonectomymedicineLung transplantationHumansPneumonectomyVascular FistulaLungbusiness.industryRespiratory diseaserespiratory systemmedicine.diseaseBronchial FistulaSurgeryTransplantationmedicine.anatomical_structureTreatment OutcomeSurgeryBronchial FistulaComplicationbusinessCardiology and Cardiovascular MedicineFollow-Up StudiesLung TransplantationThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Retrospective Analysis of 29 Patients with Multiple Pulmonary Metastases from Colorectal Carcinoma Resected by a 1318-nm Laser

2018

NO Abstract

AdultMalemedicine.medical_specialtyLung NeoplasmsColorectal cancerTreatment outcomeMEDLINEColorectal Neoplasm030204 cardiovascular system & hematologyFollow-Up Studie03 medical and health sciences0302 clinical medicineRetrospective StudiePositron Emission Tomography Computed TomographyRetrospective analysisMedicineHumansPneumonectomyPositron Emission Tomography-Computed TomographyRetrospective StudiesAgedNeoplasm StagingAged 80 and overbusiness.industryFollow up studiesMetastasectomyRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseLung NeoplasmTreatment OutcomeThoracotomy030220 oncology & carcinogenesisNeoplasm stagingFemaleRadiologyLaser TherapybusinessColorectal NeoplasmsFollow-Up StudiesHuman
researchProduct

Pulmonary artery sarcoma with angiosarcoma phenotype mimicking pleomorphic malignant fibrous histiocytoma: a case report

2012

Abstract Primary sarcomas of the major blood vessels can be classified based on location in relationship to the wall or by histologic type. Angiosarcomas are malignant neoplasms that arise from the endothelial lining of the blood vessels; those arising in the intimal compartment of pulmonary artery are rare. We report a case of pulmonary artery angiosarcoma in a 36-year old female with pulmonary masses. The patient had no other primary malignant neoplasm, thus excluding a metastatic lesion. Gross examination revealed a thickened right pulmonary artery and a necrotic and hemorrhagic tumor, filling and occluding the vascular lumen. The mass extended distally, within the pulmonary vasculature …

Adultmedicine.medical_specialtyPathologyHistologyBiopsyHemangiosarcomaCase ReportHistiocytoma Malignant FibrousPathology and Forensic MedicinePredictive Value of Testsmedicine.arteryVascular NeoplasmBiomarkers TumorAngiosarcomalcsh:PathologyMedicineHumansAngiosarcomaDiagnostic ErrorsPneumonectomyCell ProliferationPulmonary Artery AngiosarcomaLungbusiness.industrySarcomaGeneral Medicinemedicine.diseaseRight pulmonary arteryImmunohistochemistryVascular NeoplasmsPulmonary arteryHemangiosarcomamedicine.anatomical_structurePhenotypeTreatment OutcomeChemotherapy AdjuvantPulmonary arteryFemaleSarcomaRadiologybusinessTomography X-Ray Computedlcsh:RB1-214Diagnostic Pathology
researchProduct

Successful treatment of a patient with ARDS after pneumonectomy using high-frequency oscillatory ventilation.

1999

High frequency oscillatory ventilation (HFOV) was used in a patient who developed the acute respiratory distress syndrome 5 days following a right pneumonectomy for bronchogenic carcinoma. When conventional pressure-controlled ventilation failed to maintain adequate oxygenation, HFOV dramatically improved oxygenation within the first few hours of therapy. Pulmonary function and gas exchange recovered during a 10-day period of HFOV. No negative side effects were observed. Early use of HFOV may be a beneficial ventilation strategy for adults with acute pulmonary failure, even in the postoperative period after lung resection.

Artificial ventilationMaleARDSLung NeoplasmsCritical Caremedicine.medical_treatmentHigh-Frequency VentilationCritical Care and Intensive Care MedicinePulmonary function testingPneumonectomyIntensive caremedicineHumansPneumonectomyMechanical ventilationPostoperative CareRespiratory Distress Syndromebusiness.industryPulmonary Gas ExchangeAirway ResistanceHigh-frequency ventilationMiddle Agedmedicine.diseaseRespiration ArtificialRadiographyCarcinoma BronchogenicAnesthesiaBreathingBlood Gas AnalysisEmergenciesbusinessIntensive care medicine
researchProduct